Cracking The Code: Understanding Analyst Reviews For QuidelOrtho
Portfolio Pulse from Benzinga Insights
Analyst reviews for QuidelOrtho (NASDAQ:QDEL) show a mix of bullish and bearish perspectives. Recent ratings include 1 bullish, 2 somewhat bullish, and 1 indifferent. Analysts have set a 12-month average price target of $57.25, up from $51.00. Financial challenges include a -4.22% revenue decline and a net margin of -23.19%.
September 19, 2024 | 9:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
QuidelOrtho has received mixed analyst ratings with a recent increase in the average price target to $57.25. Despite financial challenges like a -4.22% revenue decline and a net margin of -23.19%, analysts show some optimism.
The mixed analyst ratings and increased price target suggest a neutral short-term impact on QDEL's stock price. While financial challenges exist, the optimism from analysts could balance the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100